Compugen Ltd (CGEN)

[midastouch017]

Compugen to Present at the BioInvestor Forum
Monday October 17, 9:00 am ET


TEL AVIV, Israel--(BUSINESS WIRE)--Oct. 17, 2005--Compugen Ltd. (Nasdaq:CGEN - News) announced today that Alon Amit, Ph.D., Vice President Science and Technology, Compugen USA Inc., is scheduled to present at the upcoming BIO InvestorForum at 11:20 AM (Pacific Time) on Thursday, October 20, 2005 at the Palace Hotel in San Francisco.

A live Webcast of the presentation will be available at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=CGEN&item_id =1148678 (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.) on Thursday, October 20, 2005 at 11:20 AM PT / 01:20 PM ET, and a replay will be available for 90 days following the presentation.

About Compugen

Compugen is a drug and diagnostic discovery company incorporating ideas and methods from mathematics, computer science, and physics into biology, chemistry, and medicine. The Company's powerful predictive models and discovery engines are both advancing the understanding of important biological phenomena and enabling the discovery of numerous potential therapeutic products and diagnostic markers. The Company has an early stage in-house pipeline consisting of selected therapeutic protein candidates discovered by the Company; additional discoveries have been out-licensed for development. Among Compugen's customers and partners are leading pharmaceutical and diagnostic companies, such as Abbott Laboratories, Diagnostic Products Corporation, Novartis, and Ortho-Clinical Diagnostics, a Johnson & Johnson company. Compugen has established a small-molecule drug discovery affiliate -- Keddem Bioscience, and an agricultural biotechnology affiliate -- Evogene. For additional information, please visit Compugen's corporate Website at www.cgen.com.

http://biz.yahoo.com/bw/051017/175598.html?.v=1

Dubi